Antagonism of N-methyl-D-asparate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior

L. D. Snell, K. M. Johnson

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Representatives from several chemical classes known to share behavioral properties with phencyclidine [(1-phenylcyclohexyl)piperidine] (PCP) have been shown to antagonize the excitatory effects of N-methylaspartate on spinal neurons selectively. This study compared the abilities of several of these PCP-like drugs to inhibit N-methyl-D-aspartate (NMDA)-stimulated efflux of acetylcholine in rat striatum. PCP completely inhibited this parameter with an IC50 value of 68 nM. The IC50 values (nanomolar) found for the other drugs tested were as follows: etoxadrol (98), (-)-cyclazocine (120), N-allylnormetazocine (or SKF 10047) (940), ketamine (1600) and ethylketocyclazocine (8300). Morphine had no effect at concentrations as high as 30,000 nM. In addition, 100 nM dexoxadrol, 1-[1-(naphthyl)cyclohexyl]piperidine HCl (m-amino PCP) and (-)-cyclazocine inhibited NMDA-induced acetylcholine release by about 50%, whereas the same concentration of their enantiomers (or a structural analog in the case of m-amino-PCP) produced no significant effect. It was also found that 10 mg/kg of dexoxadrol, m-amino-PCP and (-)-cyclazocine induced significant ipsilateral turning in rats with unilateral destruction of the substantia nigra, whereas 10 mg/kg of levoxadrol, 1-[1-(m-nitrophenyl)cyclohexyl]piperidine HCL (m-nitro-PCP) and (+)-cyclazocine produced no such similar effect. In spite of the ability of several dopaminergic antagonists to block turning produced by (±)-cyclozocine, we concluded, based on our previously reported studies of the dopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of the PCP-like drugs. This was substantiated by the observation that haloperidol had no effect on the inhibition of PCP of the NMDA response. Comparison of rank order potencies in inducing ipsilateral turning and in inhibiting NMDA-induced acetylcholine release suggests the possibility that PCP-like drugs may elicit turning via this indirect 'anticholinergic' effect. Similar comparisons with their reported affinity for the site labeled by [3H]PCP suggests that the action of PCP-like drugs to modulate the NMDA response may be a consequence of binding to the PCP/sigma receptor.

Original languageEnglish (US)
Pages (from-to)50-57
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume235
Issue number1
StatePublished - 1985

Fingerprint

Pharmaceutical Preparations
Cyclazocine
N-Methylaspartate
Acetylcholine
Aptitude
piperidine
Inhibitory Concentration 50
Ethylketocyclazocine
sigma Receptors
Dopamine Agents
Dopamine Antagonists
Ketamine
Cholinergic Antagonists
Substantia Nigra
Haloperidol
Morphine
Neurons

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{6b4b466bd4bc47adb50e6b6cd2671c41,
title = "Antagonism of N-methyl-D-asparate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior",
abstract = "Representatives from several chemical classes known to share behavioral properties with phencyclidine [(1-phenylcyclohexyl)piperidine] (PCP) have been shown to antagonize the excitatory effects of N-methylaspartate on spinal neurons selectively. This study compared the abilities of several of these PCP-like drugs to inhibit N-methyl-D-aspartate (NMDA)-stimulated efflux of acetylcholine in rat striatum. PCP completely inhibited this parameter with an IC50 value of 68 nM. The IC50 values (nanomolar) found for the other drugs tested were as follows: etoxadrol (98), (-)-cyclazocine (120), N-allylnormetazocine (or SKF 10047) (940), ketamine (1600) and ethylketocyclazocine (8300). Morphine had no effect at concentrations as high as 30,000 nM. In addition, 100 nM dexoxadrol, 1-[1-(naphthyl)cyclohexyl]piperidine HCl (m-amino PCP) and (-)-cyclazocine inhibited NMDA-induced acetylcholine release by about 50{\%}, whereas the same concentration of their enantiomers (or a structural analog in the case of m-amino-PCP) produced no significant effect. It was also found that 10 mg/kg of dexoxadrol, m-amino-PCP and (-)-cyclazocine induced significant ipsilateral turning in rats with unilateral destruction of the substantia nigra, whereas 10 mg/kg of levoxadrol, 1-[1-(m-nitrophenyl)cyclohexyl]piperidine HCL (m-nitro-PCP) and (+)-cyclazocine produced no such similar effect. In spite of the ability of several dopaminergic antagonists to block turning produced by (±)-cyclozocine, we concluded, based on our previously reported studies of the dopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of the PCP-like drugs. This was substantiated by the observation that haloperidol had no effect on the inhibition of PCP of the NMDA response. Comparison of rank order potencies in inducing ipsilateral turning and in inhibiting NMDA-induced acetylcholine release suggests the possibility that PCP-like drugs may elicit turning via this indirect 'anticholinergic' effect. Similar comparisons with their reported affinity for the site labeled by [3H]PCP suggests that the action of PCP-like drugs to modulate the NMDA response may be a consequence of binding to the PCP/sigma receptor.",
author = "Snell, {L. D.} and Johnson, {K. M.}",
year = "1985",
language = "English (US)",
volume = "235",
pages = "50--57",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Antagonism of N-methyl-D-asparate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior

AU - Snell, L. D.

AU - Johnson, K. M.

PY - 1985

Y1 - 1985

N2 - Representatives from several chemical classes known to share behavioral properties with phencyclidine [(1-phenylcyclohexyl)piperidine] (PCP) have been shown to antagonize the excitatory effects of N-methylaspartate on spinal neurons selectively. This study compared the abilities of several of these PCP-like drugs to inhibit N-methyl-D-aspartate (NMDA)-stimulated efflux of acetylcholine in rat striatum. PCP completely inhibited this parameter with an IC50 value of 68 nM. The IC50 values (nanomolar) found for the other drugs tested were as follows: etoxadrol (98), (-)-cyclazocine (120), N-allylnormetazocine (or SKF 10047) (940), ketamine (1600) and ethylketocyclazocine (8300). Morphine had no effect at concentrations as high as 30,000 nM. In addition, 100 nM dexoxadrol, 1-[1-(naphthyl)cyclohexyl]piperidine HCl (m-amino PCP) and (-)-cyclazocine inhibited NMDA-induced acetylcholine release by about 50%, whereas the same concentration of their enantiomers (or a structural analog in the case of m-amino-PCP) produced no significant effect. It was also found that 10 mg/kg of dexoxadrol, m-amino-PCP and (-)-cyclazocine induced significant ipsilateral turning in rats with unilateral destruction of the substantia nigra, whereas 10 mg/kg of levoxadrol, 1-[1-(m-nitrophenyl)cyclohexyl]piperidine HCL (m-nitro-PCP) and (+)-cyclazocine produced no such similar effect. In spite of the ability of several dopaminergic antagonists to block turning produced by (±)-cyclozocine, we concluded, based on our previously reported studies of the dopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of the PCP-like drugs. This was substantiated by the observation that haloperidol had no effect on the inhibition of PCP of the NMDA response. Comparison of rank order potencies in inducing ipsilateral turning and in inhibiting NMDA-induced acetylcholine release suggests the possibility that PCP-like drugs may elicit turning via this indirect 'anticholinergic' effect. Similar comparisons with their reported affinity for the site labeled by [3H]PCP suggests that the action of PCP-like drugs to modulate the NMDA response may be a consequence of binding to the PCP/sigma receptor.

AB - Representatives from several chemical classes known to share behavioral properties with phencyclidine [(1-phenylcyclohexyl)piperidine] (PCP) have been shown to antagonize the excitatory effects of N-methylaspartate on spinal neurons selectively. This study compared the abilities of several of these PCP-like drugs to inhibit N-methyl-D-aspartate (NMDA)-stimulated efflux of acetylcholine in rat striatum. PCP completely inhibited this parameter with an IC50 value of 68 nM. The IC50 values (nanomolar) found for the other drugs tested were as follows: etoxadrol (98), (-)-cyclazocine (120), N-allylnormetazocine (or SKF 10047) (940), ketamine (1600) and ethylketocyclazocine (8300). Morphine had no effect at concentrations as high as 30,000 nM. In addition, 100 nM dexoxadrol, 1-[1-(naphthyl)cyclohexyl]piperidine HCl (m-amino PCP) and (-)-cyclazocine inhibited NMDA-induced acetylcholine release by about 50%, whereas the same concentration of their enantiomers (or a structural analog in the case of m-amino-PCP) produced no significant effect. It was also found that 10 mg/kg of dexoxadrol, m-amino-PCP and (-)-cyclazocine induced significant ipsilateral turning in rats with unilateral destruction of the substantia nigra, whereas 10 mg/kg of levoxadrol, 1-[1-(m-nitrophenyl)cyclohexyl]piperidine HCL (m-nitro-PCP) and (+)-cyclazocine produced no such similar effect. In spite of the ability of several dopaminergic antagonists to block turning produced by (±)-cyclozocine, we concluded, based on our previously reported studies of the dopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of these drugs, that turning is the result of nondopaminergic properties of the PCP-like drugs. This was substantiated by the observation that haloperidol had no effect on the inhibition of PCP of the NMDA response. Comparison of rank order potencies in inducing ipsilateral turning and in inhibiting NMDA-induced acetylcholine release suggests the possibility that PCP-like drugs may elicit turning via this indirect 'anticholinergic' effect. Similar comparisons with their reported affinity for the site labeled by [3H]PCP suggests that the action of PCP-like drugs to modulate the NMDA response may be a consequence of binding to the PCP/sigma receptor.

UR - http://www.scopus.com/inward/record.url?scp=0021997493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021997493&partnerID=8YFLogxK

M3 - Article

C2 - 2864436

AN - SCOPUS:0021997493

VL - 235

SP - 50

EP - 57

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -